BIIB
Biogen Inc.
A biopharmaceutical company focused on the brain and nervous system, Biogen makes treatments for multiple sclerosis, spinal muscular atrophy, ALS, and Alzheimer's — with brands like TYSABRI, SPINRAZA, and the Alzheimer's drug LEQEMBI it co-markets with Eisai. It was founded in 1978 in Geneva by academic scientists (including two future Nobel laureates) and later moved to Cambridge, Massachusetts, where it remains. Its name is a mash-up of "Biotechnology Geneva," and its roots stretch back to the dawn of the biotech industry.
CUSIP: 09062X103HealthcareUS4 holders1 derivative reporter
Total Value
$128.81M
Total Shares
596.2K
Net Share Change
-108.0K
Activity
4 selling
Investor
Value
Shares
Weight
Change
